Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
6
×
boston blog main
boston top stories
6
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
medicare
biotech
cancer immunotherapy
deals
eli lilly
pfizer
startups
abbvie
bristol-myers squibb
cancer
clinical trials
drug prices
What
drug
6
×
bio
roundup
alzheimer’s
price
biogen’s
companies
nash
news
prices
week
acquisitions
administration
aducanumab
albert
amyloid
angry
angst
annual
anti
approval
assessed
attention
bagged
benefited
biggest
billions
biogen
biopharmaceutical
biotech
bourla
brammer
ceo
communities
company
conference
convo
crispr
despite
different
Language
unknown
Current search:
biogen
×
drug
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More